Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct Therapy
Clinical trial NCT03592706 · UNKNOWN
Trial details
- NCT number
- NCT03592706
- Sponsor
- Ivy Life Sciences, Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2021-02-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.